Alexander Y. Walley, MD, MSc; Traci C. Green, PhD, MSc
This article was published at www.annals.org on 28 June 2016.
Grant Support: Drs. Walley and Green are supported by grants from the Agency for Healthcare Research and Quality (R18 HS024021) and the National Institute on Drug Abuse (R01DA038082). Dr. Walley is also supported by additional grants from the National Institute on Drug Abuse (R01DA037768 and R25D13582) and a grant from the National Institute on Alcohol Abuse and Alcoholism (U01AA020784).
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1348.
Requests for Single Reprints: Alexander Y. Walley, MD, MSc, Boston University School of Medicine and Boston Medical Center, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02118; e-mail, email@example.com.
Current Author Addresses: Dr. Walley: Boston University School of Medicine and Boston Medical Center, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02118.
Dr. Green: Boston University School of Medicine and Boston Medical Center, Injury Prevention Center, Department of Emergency Medicine, 1 Boston Medical Center Place, Boston, MA 02118.
Walley A., Green T.; Mainstreaming Naloxone Through Coprescription to Patients Receiving Long-Term Opioid Therapy for Chronic Pain. Ann Intern Med. 2016;165:292-293. doi: 10.7326/M16-1348
Download citation file:
Published: Ann Intern Med. 2016;165(4):292-293.
Published at www.annals.org on 28 June 2016
Coffin and colleagues report results of the NOSE (Naloxone for Opioid Safety Evaluation) study, which evaluated the implementation of overdose education and prescription of naloxone rescue kits (OENRKs) among patients in safety net community health centers who were treated with opioid therapy for chronic pain (1). They found that more than one third of patients were prescribed naloxone rescue kits, and prescription rates were highest among those with previous emergency department (ED) visits and higher opioid doses. Patients who were prescribed naloxone had substantially fewer opioid-related ED visits and no net change in the prescribed morphine-equivalent opioid dose compared with those who were not prescribed naloxone. The authors used rigorous observational methods to evaluate an innovative intervention for overdose prevention.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Emergency Medicine, Pulmonary/Critical Care, Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only